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activates satellite cells in the mouse urethral
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Background: The goal of this study is to demonstrate the efficacy of a new method for the treatment of urinary
incontinence by stimulation of urethral rhabdosphincter satellite cells. We show that satellite cells do exist in the
sphincter muscle of retired male mice breeders by staining for c-Met, a satellite cell specific protein. Once activated
by recombinant mouse Insulin-like Growth Factor-1(rIgf-1), the satellite cells develop into muscle cells within the
rhabdosphincter thereby potentially strengthening it.
Methods: 20 μl (1 μg/μl) of rIgf-1 was surgically injected directly into the urethral wall of retired male mouse breeders.
Mice injected with phosphate buffered saline (PBS) were used as controls. 4 weeks later, urethras were harvested and
serially-sectioned through the sphincter for routine hematoxylin-eosin staining as well as immunohistochemical staining
with satellite cell specific anti-c-Met antibody and proliferation specific anti-Ki-67 antibody.
Results: Anti-c-Met antibody positive cells (c-Met+) were identified in the rhabdosphincter. c-Met+ cells increased by
161.8% relative to controls four weeks after rIGF-1 injection. Anti- Ki-67 antibody positive cells were identified and
characterized as cells with centrally located nuclei in striated muscle bundles of rIGF-1 treated animals.
Conclusions: Satellite cells in the mouse rhabdosphincter can be activated by rIGF-1 treatment, which subsequently
are incorporated into existing skeletal muscle bundles. Using this approach, the rhabdosphincter can be induced to
regenerate and potentially strengthen via satellite cell activation and likely improve urinary continence.
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Incontinence affects both adult females and males. In
the adult population, urinary incontinence affects an
estimated 35% of women 65 years or older and 10% of
women younger than 65 years. An estimated 22% of
men 65 years or older and 1.5% of men younger than 65
and 30 to 50% of institutionalized adults 65 years or
older also have some form of urinary incontinence [1].
Many studies have underscored the role of the rhabdo-
sphincter in mediating continence. Although stress urinary
incontinence (SUI) is a common form of incontinence that
primarily affects women, its pathophysiology has remained* Correspondence: wenjie@dental.upenn.edu
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stated.elusive. It is likely, however, that anatomical factors such as
urethral hypermobility may contribute to urethral incom-
petence. Hilton et al. found that the degree of sphincter
weakness, as evidenced by decreased maximum urethral
closure pressure (MUCP), correlates with the severity of
SUI [2]. Rhabdosphincter volume is significantly smaller
on ultrasound examination in SUI woman compared to
continent controls underscoring the role of muscle mass in
maintaining continence [3,4]. Strasser found that the dra-
matic decrease in the number of striated muscle cells in
the rhabdosphincter of elderly patients, owing to apoptosis,
represents the morphological basis for high incidence of
incontinence in that population [5]. Also, Perucchini et al.
found that the number and the density of urethral striated
muscle fibers decline with age [6]. Thus, SUI correlates
with loss of closing pressure which in turn appears related
to striated sphincter muscle mass.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 Anatomy and surgical exposure. A: Male mouse urethra
comprises 3 parts, an anatomy which is similar to that found in
humans: the prostatic urethra, the membrane urethra and the
spongy urethra. The membrane urethra is the section between the
prostate and diagram, it is approximately 0.8 to 1.2 cm in length and
it can be easily surgically exposed for local injections. B: After a low
abdominal mid-line incision was made, the male mouse urethra was
exposed for injection in the lateral aspects of the urethra.
Wei et al. BMC Urology 2013, 13:62 Page 2 of 7
http://www.biomedcentral.com/1471-2490/13/62Radical prostatectomy is widely employed as primary
treatment for localized prostate cancer. The rates of post-
prostatectomy incontinence range from 5%-65% and have
significant impact on patient quality of life issues [7-10].
Post- prostatectomy incontinence may be attributed to
sphincter dysfunction that occurs as a direct result of sur-
gical injury during the radical prostatectomy [11-13].
Duloxetine, a potent serotonin and norepinephrine re-
uptake inhibitor, stimulates the pudendal nerve output
to the striated urethral sphincter as a result of the in-
creased levels of serotonin and norepinephrine in the
pudendal nerve nucleus in the sacral spinal cord [14].
Clinically, significant improvements in patients suf-
fering from SUI have been demonstrated in studies by
Ghoniem et al. [15]. Thus, we can presume, on the basis
of these studies, that incontinence can either be im-
proved or cured by enhancing the quantity and/or quality
of functioning striated urethral muscle.
Satellite cells, the skeletal muscle stem cells, have been
identified in a variety of muscle tissues. It has been dem-
onstrated that skeletal muscle satellite cells, if appropri-
ately stimulated, for example, by IGF-1, will proliferate
and differentiate into mature skeletal muscle cells [16-18].
The rejuvenation of satellite cells in the aged rhabdo-
sphincter has been previously demonstrated [19,20]. In
this study, we show that satellite cells do exist in the
sphincter muscle of retired male mice breeders by staining
for c-Met, a satellite cell specific protein which is the re-
ceptor for Hepatocyte Growth Factor (HGF) [17,21]. Once




Retired (4 month old) Swiss Webster mice (Charles
River), weighing 30–46 grams, were used. A low abdominal
midline incision was made under isoflurane anesthesia.10 μl
of 1 μg/μl recombinant mouse IGF-1 (R&D system, 791-
MG) was injected, using a Hamilton micro-injector with
30G needle, in the each lateral side of the urethra after its
surgical exposure. After injection of IGF-1, the inci-
sion was closed, followed by administration of 0.1 ml
0.03 mg/ml buprenophine to relieve post-surgical pain.
4 weeks after surgery, the mice were sacrificed and the
urethral tissue was harvested for analysis. Sham-operated
controls were treated identically except that PBS was
injected in place of IGF-1. Three mice were used in each
group. The animal study was approved by IACUC of
University of Pennsylvania.
Histological analysis
The lower urinary tract from the bladder to the glans
penis was carefully dissected and removed for histological
analysis. Initially, to study potential rIGF-1 accessibility tosatellite cells in the muscle bundle, Indian ink was locally
injected into the urethral wall in the region just below the
prostate. The urethra was serially sectioned at 7um for rou-
tine H& E staining. Muscle bundles containing central nu-
clei were assumed to be new muscle bundles.
Immunohistochemistry
Urethras were excised and embedded in O.C.T for cryo-
sectioning. To detect c-Met, the sections were swollen
by treatment with 0.5 M acetic acid for 6 hours to ex-
pose c-Met antigen and rinsed with PBS. Sections were
then incubated with goat anti-mouse c-Met antibody
in a humidified chamber (R&D. AF527) 1:100 at 4°C
overnight, followed by 3 PBS washes and incubation
with Alex fluor-594 linked rabbit anti-goat IgG-fab 1:
200 dilution (Invitrogen) for 1 hour. To detect ki-67,
sections were incubated with 1:600 dilution rabbit
anti-human Ki67 (NCL-ki67p polyclonal, Novo Castro)
at 4°C overnight. Sections were then washed 3× with PBS
and incubated with Alex fluor-594 linked goat anti rabbit
IgG-fab, 1: 200 dilution, (Invitrogen) for 1 hour at room
temperature. The sensibility and specificity of the anti-
bodies used in these studies have been confirmed by
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stained by Chromomycin A3 (0.1 mg/ml, Sigma) for
10 minutes at room temperature. Using fluorescence
microscopy, cells found at the periphery of muscle bun-
dles stain red with c-Met antibody and Alex Flour-594
conjugated secondary antibody demonstrating that they
are satellite cells. Nuclei were stained with chromo-
mycin A3, which appears green. The co-localization of
c-Met and chromomycin appears yellow. Yellow cells
were thus identified as satellite cells. To quantify the
number of satellite cells in the U-RS, c-Met positive
cells were counted in 3 random fields from each section
(3 sections per animal). Images were captured using
a Nikon Digital Camera system. Image J was software
was used to align the individual images to demonstrate
the co-localization of either c-Met or Ki67 positive staining
with nuclei.
Statistical analysis
one-ANOVA and student-t test were used to determine
significance among and between 2 groups, respectively.Figure 2 Locally injected rIGF-1 accessibility to satellite cells in male mo
urethra. The inner layer consists of mucosa and sub-mucosa, the outer layer is
muscle goes along and surrounds the urethral lumen. C, D: Injection of India in
by locally injected India ink, demonstrating potential accessibility of injections tResults
Anatomy and surgical exposure
The 42 g Swiss Webster male mouse urethra is about
2.7 cm in length and consists of 3 parts which are simi-
lar to those found in humans: the prostatic urethra, the
membrane urethra and the spongy urethra. The mem-
brane urethra is the section below the prostate and
above the diagram and is approximately 0.8 to 1.2 cm
long and can be surgically exposed for local injection
(Figure 1A, 1B).
Locally injected rIGF-1 accessibility to satellite cells
For histological analysis, the urethra was serially sec-
tioned at 7 um for normal H & E staining. Three layers
which surround the urethral lumen can be demonstrated.
The inner layer is combined mucosa and sub-mucosa,
the outer layer is serosa. The middle layer is the urethral
rhabdosphincter (U-RS) muscle layer, it contains the
rhabdo-muscle which extends longitudinally and sur-
rounds the urethral lumen. (Figure 2A, 2B) To dem-
onstrate potential rIGF-1 accessibility to satellite cells inuse urethra rhabdosphincter. A, B: Cross section of the male membrane
a serosa and the middle layer is muscle layer contains the rhabdosphincter
k into the urethral rhabdosphincter. The rhabdosphincter was infiltrated
o satellite cells within the muscle.
Figure 4 Anti-c-Met positive satellite cells in animals treated
with rIGF-1. In urethras injected with rIGF-1, the number of
c-Met + satellite cells increased significantly versus PBS-injected or
non-operated controls. Four weeks after treatment with rIGF-1,
c-Met+ satellite cells increased by 161.8% (41.1 ± 5.4 verse 15.7 ± 1.3,
p = 0.012), while the sham operated (PBS) group showed no significant
change (20.4 ± 3.9 verse 15.7 ± 1.3, p = 0.316).
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membrane urethra (Figure 2C, 2D).
Satellite cells (c-Met+) exist in retired male mouse U-RS
To detect and demonstrate the presence of satellite cells,
the U-RS was stained with an antibody to c-met. All
nuclei, including those of satellite cells were stained with
Chromomycin A3. Satellite cells, however, were thus
double stained with both Chromomycin A and c-met while
non satellite cell only stained with Chromomycin A as
shown in Figure 3.
Stimulation of satellite cells (c-Met+) after rIGF-1
treatment
Mice U-RS were injected with rIGF-1 and sacrificed
after 4 weeks of treatment. To quantify the number of
satellite cells in the U- RS, c-Met positive cells were
counted in 3 random fields from each section (3 sections
per animal). The numbers of c-Met positive cells in the
U-RS of IGF-1 treated, sham-operated and non-operated
animals are shown in Figure 4. Four weeks after treat-
ment with rIGF-1, satellite cells (c-met+) increased by
161.8% (41.1 ± 5.4 verse 15.7 ± 1.3, p = 0.012), comparing
to the non-operated controls; while the sham-operatedFigure 3 Satellite cells (c-Met+) exist in retired male mouse urethral rhabdosphincter. There is positive staining with anti-c-Met antibody at
the muscle periphery bundle demonstrating the presence of satellite cells (red). Nuclei were stained with chromomycin A3 (green). Merged
images show co-localization (yellow). A non-operated control; B: rIGF-1 Injected urethral rhabdosphincter.
Figure 6 New muscle cells were incorporated into muscle
bundles after rIGF-1 injection. Skeletal muscle cells with central
nuclei are present in the rhabdosphincter muscle bundles (arrows)
which have differentiated from satellite cells. Cells with central nuclei
were not detected in the controls.
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operated controls (20.4 ± 3.9 verse 15.7 ± 1.3, p = 0.316).
Proliferation of satellite cells were demonstrated Ki-67+
after rIGF-1
To demonstrate that the increase in the number of the
satellite cells in the U-RS was the result of de-novo mitosis
after stimulation by rIGF-1, ki-67 antibody staining was
carried out. Ki-67 is a protein which is only expressed in
dividing cells [22] and staining with an antibody to Ki-67
was used to detect the mitotic activity arising after injec-
tion of the U-RS with rIGF-1. To obtain the total number
of cells within the U-RS, all nuclei were stained with chro-
momycin A3. Ki-67 positive cells were found on the per-
ipheral zone of the muscle bundles located with the U-RS
as shown in Figure 5.
New muscle cells were demonstrated with central nuclei
in muscle after rIGF-1
To demonstrate that the satellite cells which arose after
rIGF-1 injection differentiated into new striated muscle
cells with the U-RS, serial sections of the injected muscle
tissue were obtained and stained with H&E. These sections
show the presence of skeletal muscle cells with centralFigure 5 Proliferation of satellite cells after rIGF-1 injection. Cells within the rhabdosphincter stained with anti-ki67 antibody (red)
indicating cell proliferation. Nuclei were stained with chromomycin A3 (green). Note the co-localization (yellow) in the
merged photograph.
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muscle [23] (Figure 6).
Discussion
Skeletal muscle is normally a post-mitotic tissue; how-
ever, when appropriately stimulated, it can increase in
mass. When this occurs, it is predominantly owing to
the activation, proliferation and fusion of satellite cells.
Satellite cells, which are muscle-derived stem cells, are
believed to be pluripotent, and when appropriately stim-
ulated, divide and become assimilated within exiting
myofibers [16,17,24-26]. They are normally quiescent
and reside beneath the basal lamina of adult skeletal
muscle closely juxtaposed against mature skeletal muscle
fibers. The satellite cell population accounts for 2-5% of
total nuclei in adult muscle [27,28]. As demonstrated
in these studies, they can be activated by treatment with
rIGF-1 to differentiate into muscle tissue to, in effect, re-
generate and increase the mass of muscle [27]. Since the
U-RS is believed to weaken in aging adults, and since a
weakened U-RS is believed to underlie many of the
symptoms associated with stress urinary incontinence,
treatment of affected individuals with rIGF-1 has great
potential for improving their quality of life by strength-
ening the rhabdosphincter.
The human rhabdosphincter (RS) is a collar of skeletal
muscle which surrounds the urethra, permitting it to
clamp shut closing off the flow of urine from the bladder.
The damage to the RS during prostatectomy can result in
male incontinence. Similar to the human, the male mouse
urethra contains a segment between the prostate and the
urogenital diagram which is surrounded by sphincteric
muscle whose contraction leads to the closure of urethra.
This segment can be easily surgically exposed for local in-
jection in the mouse.
In these studies, we have demonstrated the existence
of satellite cells in the mouse U-RS which can be in-
duced to divide and differentiate into muscle tissue by
injection of rIGF-1. We chose retired, older male mice
for these experiments to demonstrate that the satellite
cells being activated were not merely growing as a result
of developmental activities. However, we have also carried
out similar experiments with younger mice with similar re-
sults (data not shown). The importance of growth factors,
such as IGF-1, in promoting skeletal muscle hyperplasia
has been previously reported [29,30]. These results show
that the mouse model can be utilized to further investigate
the efficacy of this treatment for other types of incontin-
ence since the satellite cell response was robust (approxi-
mately 161.8% increase in the number of satellite cells).
New muscle fibers, characterized by central nuclei, ap-
peared 4 weeks after rIGF-1 treatment further validating
the concept that the activated satellite cells become in-
corporated into existing muscle, increasing muscle mass.The repair and/or regeneration of new muscle within
damaged or aged U-RS to improve urinary incontinence.
Because this study was carried out using an animal
model with a small sample size, further functional stud-
ies of changes in muscle contractility/physiology and
urodynamic changes which occur after treatment will
need to be carried out to further validate these data.
Nevertheless, the basic concept that treatment of the
U-RS with rIGF-1 can increase its muscle mass has been
demonstrated, indicating that this approach is potentially
useful since current treatments for stress urinary incon-
tinence (sling, suspension, and collagen bulking) are nei-
ther satisfactory nor long-lasting.
Conclusion
Satellite cells (muscle stem cells) in the aged murine
rhabdosphincter can be activated with rIGF-1 which then
develop into new muscle cells and which become incorpo-
rated into pre-existing muscle tissue. This animal model
can be used to develop new methods to regenerate and
strengthen the urethra and potentially alleviate the incon-
tinence associated with many uropathies whose root cause
is a weakened rhabdosphincter.
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